Luminex logo

LMNX - Luminex News Story

$36.69 0.0  0.1%

Last Trade - 3:25pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.23bn
Enterprise Value £1.22bn
Revenue £311.5m
Position in Universe 2333rd / 6851

BRIEF-EDP Biotech Entered Into A Non-Exclusive Agreement With Luminex Corp

Tue 28th May, 2019 12:28pm
May 28 (Reuters) - EDP Biotech:
    * EDP BIOTECH TO DEVELOP AND MARKET COLORECTAL CANCER EARLY
DETECTION BLOOD TEST USING LUMINEX XMAP TECHNOLOGY
    * EDP BIOTECH  - WILL HAVE RIGHTS TO DEVELOP, MARKET AND
SELL ITS
BLOOD-BASED COLORECTAL CANCER DIAGNOSTIC ASSAY, COLOPLEX
    * EDP BIOTECH - ENTERED INTO A NON-EXCLUSIVE AGREEMENT WITH
LUMINEX CORPORATION

Source text for Eikon:  ID:nPn4lfrP5a 
Further company coverage:  LMNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.